27/08/2023
Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility
Nội dung bài viết
Original Article
Kidney Res Clin Pract 2019;38(2):176-185
pISSN: 2211-9132 • eISSN: 2211-9140
https://doi.org/10.23876/j.krcp.18.0139
Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility
Sandra Villanueva1 , Fernando González2 , Eduardo Lorca2 , Andrés Tapia3 , Valentina López G4 , Rocío Strodthoff1 , Francisca Fajre1 , Juan E. Carreño1 , Ricardo Valjalo2 , César Vergara1 , Manuel Lecanda1 , Jorge Bartolucci4 , Fernando E. Figueroa3,5,6,* , Maroun Khoury3,4,5,*
Laboratory of Molecular and Integrative Physiology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Department of Nephrology, Hospital Salvador, Santiago, Chile
Laboratory of Nano-regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Cells for Cells, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Program for Translational Research in Cell Therapy and Consorcio Regenero, the Chilean Consortium for Regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Laboratory of Molecular and Integrative Physiology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Department of Nephrology, Hospital Salvador, Santiago, Chile
Laboratory of Nano-regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Cells for Cells, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
Program for Translational Research in Cell Therapy and Consorcio Regenero, the Chilean Consortium for Regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
